mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.098 |
0.03 |
mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.03 |
mRNA |
XMD8-85 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.03 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
0.067 |
0.03 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.03 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
0.12 |
0.03 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.03 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.03 |